Bio-Rad Laboratories, Inc. (BIO-B)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 279.91 |
| Open | 281.55 |
| Bid | 269.50 x 1400 |
| Ask | 279.10 x 800 |
| Day's range | 279.91 - 281.55 |
| 52-week range | 271.00 - 467.95 |
| Volume | |
| Avg. volume | 280 |
| Market cap | 7.917B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
New Strong Sell Stocks for April 19th
ATNI, ABR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.
- Zacks
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
© 2024 Yahoo. All rights reserved.